Ralliant Corporation Common Stock RAL 深 沪
等待开盘 09-24 09:30:00 美东时间
43.95
-0.430
-0.97%
华盛通- 最 高44.96
- 今 开44.65
- 成交量 48.80万股
- 最 低 43.855
- 昨 收 44.38
- 总市值 49.66亿
- 52周最高 54.55
- 市盈率 静 13.97
- 换手率 0.00%
- 52周最低 40.70
- 委 比 -13.79%
- 总股本 1.13亿
- 历史最高 54.55
- 量 比 0.40
- 振 幅 2.49%
- 历史最低 40.70
- 每 手 1
- 风险率 2.58%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sivers Semiconductors intends to carry out a directed share issue
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, BELARUS, SINGAPORE, SOUTH AFRICA, SO...
09-19 00:17
世喜以爱筑安，以新致远——高端喂养市场的中国标杆
（来源：衡水日报） 转自：衡水日报 在消费升级驱动的母婴市场，安全与品质成为父母的核心诉求。自 2015 年创立以来，世喜品牌始终以 “设计源于爱” 为核心理念...
09-18 14:57
Bandwidth Partners With Out There Media To Bring Next-Generation RCS For Business Capabilities To The U.S. Market
RALEIGH, N.C., Sept. 16, 2025 /PRNewswire/ -- At its Reverb25 product keynote today, Bandwidth Inc. (NASDAQ: BAND), a leading global enterprise cloud communications company, announced a partnership with Out
09-17 02:57
美股大行评级 | 最高400美元！大行纷纷连夜上调甲骨文目标价；新思科技则惨遭多家大行下调目标价
今日重点评级关注：瑞银：上调Gossamer Bio评级至"买入"，目标价从1.25美元升至9美元；Canaccord Genuity：维持Corcept Therapeutics"买入"评级，目标价从137美元升至140美元
09-11 10:06
Ralliant Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
Ratings for Ralliant (NYSE:RAL) were provided by 9 analysts in the past three m...
09-10 22:01
Oppenheimer Initiates Coverage On Ralliant with Outperform Rating, Announces Price Target of $55
Oppenheimer analyst Ian Zaffino initiates coverage on Ralliant (NYSE:RAL) with a Outperform rating and announces Price Target of $55.
09-10 19:32
Astral Limited (ASTRAL) Initiated with a Buy at UBS
Astral Limited received a Buy rating and a INR1,800.00 price target from UBS an...
09-09 23:35
CoinShares to Go Public in the U.S. Through US$1.2 Billion Business Combination
The leading European asset manager specializing in digital assets with ~US$10 billion in AuM sets sights on expanding into U.S. market CoinShares ranks among the top four managers globally b...
09-08 20:00
RedHill Biopharma Announces First Half 2025 Financial Results and Operational Highlights
Extensive strategic, financial and operational overhaul has reshaped and refocused our business; Strong progress on multiple fronts Commercial and R&D Highlights: Recruitment initiated in th...
09-05 19:00
默沙东(MRK.US)口服PCSK9第三项III期研究成功
默沙东(MRK.US)宣布Enlicitide治疗高胆固醇血症的III期CORALreef Lipids研究取得了积极结果。
09-03 21:12
